# 2025-19050: California Doctor's DEA License Yanked Over State Ban

2025-19050, Denise Henderson, M.D.; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-09-30, effective 2025-10-30; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-19050
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-19050
- Title: Denise Henderson, M.D.; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 46923
- Published: 2025-09-30
- Effective: 2025-10-30
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

California Doctor's DEA License Yanked Over State Ban

## Summary

Dr. Denise Henderson from California lost her DEA registration because she no longer has permission to handle controlled substances in her state. She didn’t ask for a hearing, so the DEA moved forward and officially revoked her registration. This means she can’t legally prescribe or manage controlled drugs anymore, effective immediately.

## Effects PRIA read

- Doctor's DEA Registration Revoked: cost, high. The DEA revoked Denise Henderson, M.D.'s Certificate of Registration No. FH2358578 because she surrendered her California physician license on April 30, 2024. She did not request a hearing after an April 21, 2025 Order to Show Cause, and the Order revoking her registration is effective October 30,…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-19050 on federalregister.gov](https://www.federalregister.gov/documents/2025/09/30/2025-19050/denise-henderson-md-decision-and-order)
- [2025-19050 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-09-30/pdf/2025-19050.pdf)

## Related
- [Previous: 2025-19049, Joint Industry Plan; Notice of Filing and Immediate Effectiveness of Amendment…](https://policyrisk.com/federal-register/2025-19049)
- [Next: 2025-19051, Agency Information Collection Activities: Requests for Comments; Clearance of a…](https://policyrisk.com/federal-register/2025-19051)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-19050 (as of 2026-06-08).
